The US FDA regulates food, medicines, cosmetics, medical devices, tobacco products and radiation electronic products. The FDA is part of the Department of Health and Human Services and is headed by the Commissioner for Food and Drug Administration, appointed by the President, and confirmed by the US Senate. The Commissioner's office oversees all Agency components and is responsible for the efficient and effective implementation of the FDA mission.
The Office of the FDA Authorized Office is divided into departments. The Health Products and Tobacco Division is overseen by the Center for Drug Evaluation and Research, which regulates drug sales in the US
The US FDA defines drugs as medical products that:
- Designed for use in the diagnosis, treatment, mitigation, treatment or prevention of diseases or diseases
- Designed to affect the structure or function of the body.
- Achieve primary function by chemical exposure
These include:
Active Pharmaceutical Ingredients (API): The active pharmaceutical ingredient is any substance or mixture of substances intended for use in the manufacture of a medicinal product, and that when used in the manufacture of a medicinal product becomes an active ingredient of the medicinal product. Such substances are intended to provide pharmacological activity or other direct effect in the diagnosis, treatment, mitigation, treatment or prevention of a disease or effect on the structure or function of the body.
Drugs for drugs: These are substances obtained in the synthesis steps of the active pharmaceutical ingredient (API) that must undergo further molecular alteration or processing before becoming an API.
Prescription drugs: is a human drug that is not safe to use, except under the supervision of a licensed physician.
Over the counter (OTC) Drugs: is a human drug that is safe and effective for use without a prescription by a licensed physician.
Homeopathic medicines: A homeopathic medicine is any drug labeled as a homeopathic medicine that is listed in the United States Homeopathic Pharmacopoeia (HPUS), added to it or its supplements.
Animal Drugs: A new drug for animals is defined, in particular, as any drug intended for use in animals other than humans, including any drug intended for use in animal feed, but not including animal feed, the composition of which is such that the agent is usually not considered safe and effective for use in the conditions prescribed, recommended or intended for labeling the drug.
Medical gases: Medical gases (eg, oxygen, carbon dioxide, helium, nitrogen, nitrous oxide, medical air, and 49 combinations of them) are narcotics within the meaning of section 201 (g) (1) of the US Federal Food, Drug, and Cosmetic Act (Act), and in accordance with section 503 (b) (1) (a) 51 of the Act, must be prescribed.
In determining the drug, the FDA is looking for evidence of objective intent, which includes circumstances related to the distribution of the article, for example, labeling, including advertising, websites, displays, etc. The FDA standard requirements for pharmaceutical companies that are sold in the US as defined in the Food, Drug, and Cosmetic Act (the “Act”).
One of the requirements of the Food and Drug Administration is the registration of drug treatment facilities. Owners or operators of all drug facilities that are not exempt in accordance with section 510 (g) of the Act, which manufacture, prepare, distribute, mix, or process human, veterinary, and biological preparations, must register and list each drug in a commercial distribution .
Here, as objects and products under FDA drug registration :
Veterinary and medical facilities
Institutions, both domestic and foreign, that produce, remark, or repackage medicinal products that are intended for import and commercial use in the United States, must be registered with the FDA. This will be done through the FDA electronic registration process. Electronic institutions registered with the FDA Annual registration status of a pharmaceutical company Web site. The information provided helps the FDA keep track of all existing drug manufacturing agencies that are sold in the US market.
The Compliance Office, Immediate Administration oversees the drug registration and registration system (DRLS) and the electronic drug registration and registration system (eDRLS), which are both key components of the FDA's drug safety capability. In 2009, the FDA announced that it would no longer accept registration of drug registration in paper format, requiring them to be presented electronically.
Registration of a drug with the FDA must be submitted annually. The Food Safety and Drug Administration (FDASIA) Law requires pharmaceutical companies to file an annual registration of the institution from October 1 to December 31 of each calendar year. Firms should also list any drugs that were not previously listed during this period.
